Covid 19 vaccine

Biological E has said it can produce 600 million doses for J&J and more than one billion doses a year of its own vaccine,…

South Africa delayed use of the vaccine after researchers found it offered minimal protection against mild-to-moderate COVID-19…

It has ordered 10 million more doses from the Serum Institute of India and 4.5 million from Bharat Biotech

The largest proportion of the ongoing vaccine trials are now in Phase II (38.6 per cent) and Phase III (36.3 per cent), after…

Mexico also has a deal with AstraZeneca to produce its vaccine for distribution in Latin America, with financial support from the…

The AstraZeneca vaccine demonstrated efficacy of around 60 per cent in the trials on which the decision was based, the European…

Serum expects a decision on an Indian trial of Novavax’s vaccine soon, said Adar Poonawalla

Novavax is stockpiling vaccine at six operating manufacturing locations and said it expects a total of eight plants in seven…

The health minister said the pandemic has also resulted in heightened nationalism, but it has also shown us how important global…

An agreement with the Pfizer has been reached, informed Paul Hudson